Search Results - "Gothelf, Anita B"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
  2. 2

    Elective Nodal Irradiation and Patterns of Failure in Head and Neck Cancer After Primary Radiation Therapy by Kjems, Julie, BScMed, Gothelf, Anita B., MD, PhD, Håkansson, Katrin, MSc, Specht, Lena, MD, DMSc, Kristensen, Claus A., MD, PhD, Friborg, Jeppe, MD, PhD

    “…Purpose The delineation of elective clinical target volumes in head and neck cancer (HNC) is important; however, the extent of lymph node levels necessary to…”
    Get full text
    Journal Article
  3. 3

    A systematic review on clinical adaptive radiotherapy for head and neck cancer by Lindegaard, Anne Marie, Håkansson, Katrin, Bernsdorf, Mogens, Gothelf, Anita B, Kristensen, Claus A, Specht, Lena, Vogelius, Ivan R, Friborg, Jeppe

    Published in Acta oncologica (02-11-2023)
    “…Head and neck cancer (HNC) patients' anatomy may undergo significant changes during radiotherapy (RT). This potentially affects dose distribution and…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Tumour control probability after Ruthenium-106 brachytherapy for choroidal melanomas by Espensen, Charlotte A, Appelt, Ane L, Fog, Lotte S, Thariat, Juliette, Gothelf, Anita B, Aznar, Marianne C, Kiilgaard, Jens F

    Published in Acta oncologica (02-08-2020)
    “…Ruthenium-106 (Ru-106) brachytherapy is a common eye-preserving treatment for choroidal melanomas. However, a dose-response model describing the relationship…”
    Get more information
    Journal Article
  6. 6

    Predicting Visual Acuity Deterioration and Radiation-Induced Toxicities after Brachytherapy for Choroidal Melanomas by Espensen, Charlotte A, Appelt, Ane L, Fog, Lotte S, Gothelf, Anita B, Thariat, Juliette, Kiilgaard, Jens F

    Published in Cancers (06-08-2019)
    “…Ruthenium-106 (Ru-106) brachytherapy is an established modality for eye-preserving treatment of choroidal melanoma. To achieve optimal treatment outcomes,…”
    Get full text
    Journal Article